Women and Infants Hospital of Rhode Island
Welcome,         Profile    Billing    Logout  
 53 Trials 
76 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Dizon, Don
BrUOG 354, NCT03355976: Nivolumab +/- Ipilimumab for Ovarian and Extra-renal Clear Cell Carcinomas

Active, not recruiting
2
46
US
Nivolumab, Ipilimumab
Brown University, Bristol-Myers Squibb, Rhode Island Hospital, The Miriam Hospital, Women and Infants Hospital of Rhode Island
Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma, Extra Renal Origin, Clear Cell Adenocarcinoma
03/25
06/25
AFT-50 EndoMAP, NCT04486352: A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer

Recruiting
1/2
148
US
Atezolizumab - 28 Day Cycle, Tecentriq, L01XC32, Bevacizumab, Avastin, L01XC07, Ipatasertib, RG7440, GDC-0068, Talazoparib, Talzenna, L01XX60, Trastuzumab emtansine, T-DM1, Kadcyla, Tiragolumab, Atezolizumab - 21 Day Cycle, Inavolisib, GDC-0077, Letrozole, Femara, Giredestrant, GDC-9545, Abemaciclib, Verzenio
Alliance Foundation Trials, LLC., Genentech, Inc., Foundation Medicine, Pfizer, Eli Lilly and Company
Endometrial Cancer
10/25
10/26
EMBER, NCT04188548 / 2019-003581-41: A Study of LY3484356 in Participants With Advanced or Metastatic Breast Cancer or Endometrial Cancer

Active, not recruiting
1
500
Europe, Japan, US, RoW
LY3484356, Imlunestrant, Abemaciclib, LY2835219, Everolimus, Alpelisib, Trastuzumab, Aromatase Inhibitor (AI), Pertuzumab
Eli Lilly and Company
Breast Cancer, Advanced Breast Cancer, Metastatic Breast Cancer, Endometrial Cancer
06/20
12/27
BrUOG 390, NCT04598321: Neoadjuvant Treatment With Talazoparib

Terminated
1
1
US
Talazoparib Oral Capsule, Talzenna
Brown University, Pfizer, Lifespan
BRCA1 Mutation, BRCA2 Mutation, Ovarian Cancer, Fallopian Tube Cancer, High Grade Serous Carcinoma
11/22
12/22
SISTERS, NCT04354454: Step Into Support for Endurance and Strength

Completed
N/A
21
US
Fitbit, Fitbit + Game + Support from a Teammate
Dana-Farber Cancer Institute
Gynecologic Cancer
12/22
03/23
SIMPRO, NCT03850912: Symptom Management Implementation of Patient Reported Outcomes in Oncology

Active, not recruiting
N/A
25000
US
eSyM App Usage, SASS Questionnaire, Qualitative Interview
Dana-Farber Cancer Institute, National Cancer Institute (NCI), RTI International, Baptist Memorial Health Care Corporation, Dartmouth-Hitchcock Medical Center, MaineHealth, West Virginia University, Lifespan
Other Cancer, Gastrointestinal Cancer, Thoracic Cancer, Gynecologic Cancer
03/23
06/25
NCT04587258: Improving Cancer Screening and Prevention During the COVID-19 Pandemic in Underserved Populations of Rhode Island

Recruiting
N/A
100
US
Informational videos and social media campaigns encouraging cancer screening.
Rhode Island Hospital, Blackstone Valley Community Health Care
Breast Cancer, Colorectal Cancer, Covid19
09/22
09/22
Sung, Vivian W
BEST, NCT05806164: Beta-Agonist Versus OnabotulinumtoxinA Trial for Urgency Urinary Incontinence

Recruiting
4
432
US
Beta3-Agonists, Adrenergic [Mirabegron/Vibegron], OnabotulinumtoxinA 100 UNT [Botox], Botox
Women and Infants Hospital of Rhode Island, University of New Mexico, University of Alabama at Birmingham, University of California, San Diego, Howard University, Brown University, Patient-Centered Outcomes Research Institute
Urgency Urinary Incontinence
07/26
07/27
BASIS, NCT06480227: Trial of Transurethral Bulking Agent Injection Versus Single-Incision Sling for Stress Urinary Incontinence

Recruiting
N/A
358
US
Solyx Single-incision Sling, Bulkamid Transurethral Bulking Agent
NICHD Pelvic Floor Disorders Network, Duke University, Kaiser Permanente, University of Chicago, University of Pennsylvania, University of Texas Southwestern Medical Center, Women and Infants Hospital of Rhode Island, RTI International, University of California, San Diego, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Stress Urinary Incontinence, Urinary Incontinence, Mixed Urinary Incontinence
08/27
08/29
TULIP, NCT06411158: Training for Urinary Leakage Improvement After Pregnancy

Recruiting
N/A
216
US
Interventionist-guided training, Home pelvic floor exercises guided by the leva® device, Education
NICHD Pelvic Floor Disorders Network, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Duke University, Kaiser Permanente, University of California, San Diego, University of Chicago, University of Pennsylvania, University of Texas Southwestern Medical Center, Women and Infants Hospital of Rhode Island, RTI International
Urinary Incontinence, Delivery Complication
11/27
11/27
Brown, Karen T
NCT03626688 / 2018-001187-33: A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients

Recruiting
3
1000
Europe, Canada, US, RoW
Ralinepag, APD811, Placebo
United Therapeutics
PAH, Pulmonary Hypertension, Pulmonary Arterial Hypertension, Hypertension, Connective Tissue Diseases, Familial Primary Pulmonary Hypertension, Vascular Diseases, Cardiovascular Diseases, Hypertension, Pulmonary, Lung Diseases, Respiratory Tract Disease
12/25
12/25
UP-FRONT, NCT05236920: Utility and Procedural Feasibility of REBOA Operationalized for Non-Trauma Application

Withdrawn
N/A
40
NA
Resuscitative Endovascular balloon occlusion of the aorta using a REBOA catheter device, REBOA procedure
University of Alabama at Birmingham
Cardiac Arrest, Out-Of-Hospital, Ventricular Fibrillation, Ventricular Tachycardia
10/22
10/22
NCT01696721: Proton and Photon Consortium Registry (PPCR): A Multi Center Registry of Pediatric Patients Treated With Radiation Therapy

Recruiting
N/A
5000
US
No intervention
Massachusetts General Hospital
Pediatric Patients Treated With Radiation Therapy
12/25
12/25
Zlotnick, Caron
ROSES-II, NCT05700760: The ROSE Scale-up Study: Informing a Decision About ROSE as Universal PPD Prevention

Recruiting
3
2320
US
ROSE (Reach Out, Stay Strong, Essentials for mothers of newborns), Enhanced Care as Usual (CAU)
Michigan State University, Pacific Institute for Research and Evaluation, Henry Ford Health System, Butler Hospital
Postpartum Depression
12/27
12/27
SURE, NCT04218864: Strength for U in Relationship Empowerment

Active, not recruiting
N/A
186
US
Strength for U in Relationship Empowerment (SURE), Attention, time, and information matched control
Women and Infants Hospital of Rhode Island, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
IPV, Perinatal, Mental Health
01/25
01/25
Scifres, Christina
iGDM, NCT05124808: Intensive Glycemic Targets in Overweight and Obese Women With Gestational Diabetes

Recruiting
N/A
828
US
Intensive glycemic targets, Standard glycemic targets
Indiana University, University of Pittsburgh, University of Alabama at Birmingham, University of Oklahoma, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Women and Infants Hospital of Rhode Island
Gestational Diabetes, Pregnancy, High Risk, Overweight and Obesity
04/26
04/26
O'Brien, Barbara
TBCRC049, NCT03501979: Tucatinib, Trastuzumab, and Capecitabine for the Treatment of HER2+ LMD

Active, not recruiting
2
17
US
Tucatinib, ONT-380, Trastuzumab, Capecitabine
University of Alabama at Birmingham, Translational Breast Cancer Research Consortium, Johns Hopkins University, Seagen Inc., University of Michigan, Georgetown University, University of California, San Francisco, University of Chicago, Indiana University, University of Washington, University of Texas
Metastatic Breast Cancer, Leptomeningeal Disease
07/21
07/24
NCT02717962: Study of VAL-083 in Patients With MGMT Unmethylated, Bevacizumab-naive Glioblastoma in the Adjuvant or Recurrent Setting

Checkmark Topline data in GBM patients who have an unmethylated promoter of the MGMT gene
Sep 2021 - Sep 2021: Topline data in GBM patients who have an unmethylated promoter of the MGMT gene
Active, not recruiting
2
119
US
VAL-083, Dianhydrogalactitol
Kintara Therapeutics, Inc.
Glioma, Glioblastoma, Glioblastoma Multiforme, GBM, Brain Cancer
12/23
03/24
NCT03994796: Genetic Testing in Guiding Treatment for Patients with Brain Metastases

Recruiting
2
186
US
Abemaciclib, PI3K Inhibitor paxalisib, Entrectinib, Adagrasib, MRTX849
Alliance for Clinical Trials in Oncology, National Cancer Institute (NCI), Mirati Therapeutics Inc., Genentech, Inc., Eli Lilly and Company, Kazia Therapeutics Limited
CDK Gene Mutation, Metastatic Malignant Neoplasm in the Brain, Metastatic Malignant Solid Neoplasm, NTRK Family Gene Mutation, PI3K Gene Mutation, ROS1 Gene Mutation, KRAS G12C Mutation
10/26
06/28
NCT05120960: A Phase 1a/1b Study to Determine the Recommended Phase 2 Dose, of Tepotinib in Participants With MET Alterations and Brain Tumors

Withdrawn
1
60
NA
tepotinib, tepotinib plus osimertinib
M.D. Anderson Cancer Center
Brain Tumor
04/24
04/24
NANO-LM, NCT06417710: Standardized Clinical Assessment of Patients With Leptomeningeal Metastasis

Recruiting
N/A
200
Europe, US
Neurological Assessment
University of Zurich, M.D. Anderson Cancer Center, The Netherlands Cancer Institute
Leptomeningeal Metastasis, Leptomeningeal Disease, Leptomeningeal Neoplasms, Leptomeningeal Cancer
12/26
12/26
NCT04988009: Patient Perceptions Around Quality of Care Through Telemedicine in Neuro-Oncology

Recruiting
N/A
200
US
Electronic Health Record Review, Survey Administration
M.D. Anderson Cancer Center
Central Nervous System Neoplasm, Leptomeningeal Neoplasm, Metastatic Malignant Neoplasm in the Brain, Primary Brain Neoplasm
12/26
12/26
Brard, Laurent
NCT02109367: Diagnostic Utility of Culdocentesis in Patients With a Suspicious Adnexal Mass

Active, not recruiting
N/A
60
US
Southern Illinois University, National Institutes of Health (NIH), National Cancer Institute (NCI)
Ovarian Cancer
12/23
06/24
Sant'Anna, Guilherme M
NCT06730490: ANS Function in HIE Infants Treated With Therapeutic Hypothermia

Completed
N/A
63
Canada
McGill University Health Centre/Research Institute of the McGill University Health Centre
Hypoxic-Ischemic Encephalopathy
12/17
12/17
PBSF, NCT03786497: Protecting Brains and Saving Futures - the Protocol

Not yet recruiting
N/A
2268
RoW
Protecting Brains Saving Futures
Brain Injuries, Congenital Heart Disease, Newborn Morbidity, Intraventricular Hemorrhage, CNS Infection, Neonatal Seizure, Nosocomial Infection, Hypoxic-Ischemic Encephalopathy, Extreme Prematurity, Brain Malformation, Congenital Infection, Neonatal Stroke, Hemodynamic Instability, Extracorporeal Membrane Oxygenation Complication, Inborn Errors of Metabolism, Respiratory Complication, Neonatal Death
12/23
12/23
DREAM, NCT05196646: Detection of CardioRespiratory Events Using Acoustic Monitoring in Preterm Infants on CPAP

Recruiting
N/A
50
Canada
Respiratory Acoustic Sensors, Nasal thermistor, MLT415/A®, ADInstruments®, Bella Vista, Australia, Respiratory Inductive Plethysmography, SleepSense®, Scientific Laboratory Products, Elgin, USA, Pneumotachometer, Hans Rudolph, Inc, Shawnee, KS
McGill University Health Centre/Research Institute of the McGill University Health Centre, Northwestern University
Apnea of Prematurity
02/25
03/25
NCT04956354: The Use of Wireless Sensors in Neonatal Intensive Care

Active, not recruiting
N/A
75
Canada
ANNE™ Monitoring System (2 sensors) - version B, ANNE™ Monitoring System (2 sensors) - version C
McGill University Health Centre/Research Institute of the McGill University Health Centre, McGill University, Northwestern University
Preterm Birth, Apnea of Newborn
09/24
07/26
PEACE, NCT06037083: Post-Extubation Assessment of Clinical Stability in ELBW Infants

Recruiting
N/A
20
Canada
Oxygen saturation probe, Near infrared spectroscopy sensors, Electrical impedance tomography
McGill University Health Centre/Research Institute of the McGill University Health Centre, St. Justine's Hospital
Extremely Low Birth Weight Infants
12/25
01/26
AWARD, NCT06693817: Advanced Wireless Sensors for Neonatal Care in the Delivery Room

Not yet recruiting
N/A
600
Canada, RoW
Wireless skin sensors vital sign monitoring system, Anne Arc (Sibel Health Inc), Radical-7 (Masimo), Wired vital sign monitoring system, Infinity M540 (Draeger)
Guilherme Sant'Anna, MD, Federal University of Uberlandia, University of Campinas, Brazil, Sanatorio de la Trinidad Palermo, Mbuya Nehanda Hospital Harare Zimbabwe, Hopsital Central de Maputo, Mozambique
Sudden Unexplained Infant Death, Apnea of Newborn, Newborn Morbidity, Newborn Asphyxia, Birth Outcome, Adverse, Birth Asphyxia, Pregnancy Related, Newborn; Vitality, ECG Electrode Site Reaction, Infant ALL, Infant Death, Infant, Newborn, Diseases, Infant Apnea, Infant Conditions, Parents, Delivery Problem for Fetus, Delivery Complication
07/26
06/27
Kearney, Robert E
NCT04123054: A Novel mHealth Application Guided by an Optimization Algorithm for T1D Sensor-Augmented Insulin Injection Users

Completed
N/A
84
Canada
Mobile App, Mobile App + Basal-Bolus Optimization Algorithm
McGill University
Diabetes Mellitus, Diabetes Mellitus, Type 1
12/23
01/24
DREAM, NCT05196646: Detection of CardioRespiratory Events Using Acoustic Monitoring in Preterm Infants on CPAP

Recruiting
N/A
50
Canada
Respiratory Acoustic Sensors, Nasal thermistor, MLT415/A®, ADInstruments®, Bella Vista, Australia, Respiratory Inductive Plethysmography, SleepSense®, Scientific Laboratory Products, Elgin, USA, Pneumotachometer, Hans Rudolph, Inc, Shawnee, KS
McGill University Health Centre/Research Institute of the McGill University Health Centre, Northwestern University
Apnea of Prematurity
02/25
03/25
NCT04956354: The Use of Wireless Sensors in Neonatal Intensive Care

Active, not recruiting
N/A
75
Canada
ANNE™ Monitoring System (2 sensors) - version B, ANNE™ Monitoring System (2 sensors) - version C
McGill University Health Centre/Research Institute of the McGill University Health Centre, McGill University, Northwestern University
Preterm Birth, Apnea of Newborn
09/24
07/26
PEACE, NCT06037083: Post-Extubation Assessment of Clinical Stability in ELBW Infants

Recruiting
N/A
20
Canada
Oxygen saturation probe, Near infrared spectroscopy sensors, Electrical impedance tomography
McGill University Health Centre/Research Institute of the McGill University Health Centre, St. Justine's Hospital
Extremely Low Birth Weight Infants
12/25
01/26
Shalish, Wissam
NCT04430790 / 2019-003666-41: Doxapram Therapy in Preterm Infants (DOXA Trial)

Recruiting
3
396
Europe, Canada
Doxapram, Dopram, Placebo, Placebo (for Doxapram)
Erasmus Medical Center, Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA), Nederlands Neonataal Netwerk (N3), the Netherlands, Universitaire Ziekenhuizen KU Leuven, Maternal, Infant, Child and Youth Research Network (MICYRN)
Apnea of Prematurity, Respiratory Insufficiency
05/26
05/34
DREAM, NCT05196646: Detection of CardioRespiratory Events Using Acoustic Monitoring in Preterm Infants on CPAP

Recruiting
N/A
50
Canada
Respiratory Acoustic Sensors, Nasal thermistor, MLT415/A®, ADInstruments®, Bella Vista, Australia, Respiratory Inductive Plethysmography, SleepSense®, Scientific Laboratory Products, Elgin, USA, Pneumotachometer, Hans Rudolph, Inc, Shawnee, KS
McGill University Health Centre/Research Institute of the McGill University Health Centre, Northwestern University
Apnea of Prematurity
02/25
03/25
NCT04956354: The Use of Wireless Sensors in Neonatal Intensive Care

Active, not recruiting
N/A
75
Canada
ANNE™ Monitoring System (2 sensors) - version B, ANNE™ Monitoring System (2 sensors) - version C
McGill University Health Centre/Research Institute of the McGill University Health Centre, McGill University, Northwestern University
Preterm Birth, Apnea of Newborn
09/24
07/26
PEACE, NCT06037083: Post-Extubation Assessment of Clinical Stability in ELBW Infants

Recruiting
N/A
20
Canada
Oxygen saturation probe, Near infrared spectroscopy sensors, Electrical impedance tomography
McGill University Health Centre/Research Institute of the McGill University Health Centre, St. Justine's Hospital
Extremely Low Birth Weight Infants
12/25
01/26
Chawla, Sanjay
NCT04214834: Trial to Shorten Pharmacologic Treatment of Newborns With Neonatal Opioid Withdrawal Syndrome (NOWS)

Active, not recruiting
3
190
US
Morphine, Methadone
Advancing Clinical Trials in Neonatal Opioid Withdrawal (ACT NOW) Program, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Neonatal Opioid Withdrawal Syndrome
01/24
06/26
Werner, Erika
DECIDE, NCT06445946: A Comparative Effectiveness Trial of Metformin Versus Insulin for the Treatment of Gestational Diabetes

Recruiting
4
1572
US
Metformin, Insulin
Ohio State University, Patient-Centered Outcomes Research Institute, The George Washington University Biostatistics Center
Gestational Diabetes Mellitus, Pregnancy, High Risk
12/29
12/30
NCT04615351: A Pragmatic Approach to Lowering the Risk of Diabetes Mellitus After A Diagnosis of Gestational Diabetes Mellitus

Recruiting
3
200
US
Metformin
Women and Infants Hospital of Rhode Island
Gestational Diabetes
10/21
06/22
NCT05280496: A Pragmatic Approach to Lower Diabetes Risk After Gestational Diabetes

Active, not recruiting
3
20
US
Metformin
Tufts Medical Center
Diabetes, Gestational, PreDiabetes, Diabetes Mellitus, Type 2
12/24
01/25
NCT05597943: MHealth Smartphone App and Postpartum Glucose Intolerance for Patients with GDM

Recruiting
N/A
30
US
Malama App
Tufts Medical Center
Gestational Diabetes, PreDiabetes, Pregnancy Related, Pregnancy, High Risk
01/25
02/25
GO MOMs, NCT04860336: Glycemic Observation and Metabolic Outcomes in Mothers and Offspring

Active, not recruiting
N/A
2150
US
Observational
Northwestern University, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Yale University, Women and Infants Hospital of Rhode Island, University of Pittsburgh, Massachusetts General Hospital, Tufts Medical Center, Columbia University, Kaiser Permanente
Gestational Diabetes, Pregnancy Related
08/25
10/25
Facco, Francesca
NCT03487185: Continuous Positive Airway Pressure (CPAP) for Sleep Apnea in Pregnancy

Recruiting
N/A
1500
US
Continuous Positive Airway Pressure, CPAP, Sleep Advice Control
The George Washington University Biostatistics Center, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Heart, Lung, and Blood Institute (NHLBI)
Obstructive Sleep Apnea of Adult, Preeclampsia, Obstetrical Complications
12/26
12/26
GO MOMs, NCT04860336: Glycemic Observation and Metabolic Outcomes in Mothers and Offspring

Active, not recruiting
N/A
2150
US
Observational
Northwestern University, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Yale University, Women and Infants Hospital of Rhode Island, University of Pittsburgh, Massachusetts General Hospital, Tufts Medical Center, Columbia University, Kaiser Permanente
Gestational Diabetes, Pregnancy Related
08/25
10/25
Moore, Richard
ENGOT-EN20, NCT05611931 / 2022-002540-42: Selinexor in Maintenance Therapy After Systemic Therapy for Participants with P53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma

Jul 2024 - Dec 2024: Top-line data from XPORT-EC trial in participants with TP53 wild type endometrial cancer
Recruiting
3
220
Europe, Canada, US, RoW
Selinexor, KPT-330, Matching Placebo for selinexor
Karyopharm Therapeutics Inc, GOG Foundation, European Network of Gynaecological Oncological Trial Groups (ENGOT), Belgium and Luxembourg Gynaecological Oncology Group, North Eastern German Society of Gynaecological Oncology, Multicentre Italian Trials in Ovarian Cancer and Gynecologic Malignancies, Spanish Research Group in Ovarian Cancer, The Central and Eastern European Gynecologic Oncology Group, Israeli Society of Gynecologic Oncology, Australia New Zealand Gynaecological Oncology Group
Endometrial Cancer
01/25
01/28
NRG-GY019, NCT04095364: Letrozole With or Without Paclitaxel and Carboplatin in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Recruiting
3
450
Europe, Canada, US, RoW
Biopsy, BIOPSY_TYPE, Bx, Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Carboplatin, Blastocarb, Carboplat, Carboplatin Hexal, Carboplatino, Carboplatinum, Carbosin, Carbosol, Carbotec, CBDCA, Displata, Ercar, JM-8, JM8, Nealorin, Novoplatinum, Paraplatin, Paraplatin AQ, Paraplatine, Platinwas, Ribocarbo, Imaging Technique, Diagnostic Imaging Technique, Image Type, Imaging, Imaging (procedure), imaging procedure, Imaging Procedures, imaging type, IMAGING_METHOD, imaging_type, Medical Imaging, Type of imaging, Letrozole, CGS 20267, Femara, Fempro, Paclitaxel, Anzatax, Asotax, Bristaxol, Praxel, Taxol, Taxol Konzentrat
NRG Oncology, National Cancer Institute (NCI)
Low Grade Fallopian Tube Serous Adenocarcinoma, Ovarian Low Grade Serous Adenocarcinoma, Primary Peritoneal Low Grade Serous Adenocarcinoma, Stage II Fallopian Tube Cancer AJCC v8, Stage II Ovarian Cancer AJCC v8, Stage II Primary Peritoneal Cancer AJCC v8, Stage III Fallopian Tube Cancer AJCC v8, Stage III Ovarian Cancer AJCC v8, Stage III Primary Peritoneal Cancer AJCC v8, Stage IV Fallopian Tube Cancer AJCC v8, Stage IV Ovarian Cancer AJCC v8, Stage IV Primary Peritoneal Cancer AJCC v8
02/27
02/28
NRG-GY026, NCT05256225: Testing the Addition of Trastuzumab or Trastuzumab/Pertuzumab to the Usual Chemotherapy for HER2 Positive Endometrial Cancer

Recruiting
2/3
525
US
Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Carboplatin, Blastocarb, Carboplat, Carboplatin Hexal, Carboplatino, Carboplatinum, Carbosin, Carbosol, Carbotec, CBDCA, Displata, Ercar, JM-8, JM8, Nealorin, Novoplatinum, Paraplatin, Paraplatin AQ, Paraplatine, Platinwas, Ribocarbo, Computed Tomography, CAT, CAT Scan, Computed Axial Tomography, Computerized Axial Tomography, Computerized axial tomography (procedure), Computerized Tomography, Computerized Tomography (CT) scan, CT, CT Scan, tomography, Echocardiography, EC, High-Dose-Rate Vaginal Cuff Brachytherapy, HDR-VCB, Hyaluronidase-zzxf/Pertuzumab/Trastuzumab, Pertuzumab and Trastuzumab hyaluronidase, Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf, Pertuzumab/Trastuzumab/Hyaluronidase-zzxf, Phesgo, Multigated Acquisition Scan, Blood Pool Scan, Equilibrium Radionuclide Angiography, Gated Blood Pool Imaging, MUGA, Radionuclide Ventriculography, RNVG, SYMA Scanning, Synchronized Multigated Acquisition Scanning, Paclitaxel, Anzatax, Asotax, Bristaxol, Praxel, Taxol, Taxol Konzentrat, Quality-of-Life Assessment, Quality of Life Assessment, Trastuzumab/Hyaluronidase-oysk, Herceptin Hylecta, Trastuzumab and Hyaluronidase, Trastuzumab and Hyaluronidase-oysk, Trastuzumab and Recombinant Human Hyaluronidase PH20, Trastuzumab and rHuPH20, Trastuzumab-Hyaluronidase-oysk
National Cancer Institute (NCI), NRG Oncology
Endometrial Carcinoma, Endometrial Clear Cell Adenocarcinoma, Endometrial Dedifferentiated Carcinoma, Endometrial Endometrioid Adenocarcinoma, Endometrial Mixed Cell Adenocarcinoma, Endometrial Serous Adenocarcinoma, Endometrial Undifferentiated Carcinoma, Uterine Corpus Carcinosarcoma
10/27
10/27
NCI-2017-01672, NCT03660826: Testing the Combination of Olaparib and Durvalumab, Cediranib and Durvalumab, Olaparib and Capivasertib, and Cediranib Alone in Recurrent or Refractory Endometrial Cancer Following the Earlier Phase of the Study That Tested Olaparib and Cediranib in Comparison to Cediranib Alone, and Olaparib Alone

Active, not recruiting
2
286
Canada, US
Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Bone Marrow Aspirate, BONE MARROW, LIQUID, Human Bone Marrow Aspirate, Bone Marrow Biopsy, Biopsy of Bone Marrow, Biopsy, Bone Marrow, Capivasertib, AZD 5363, AZD-5363, AZD5363, Truqap, Cediranib, AZ-D2171, AZD 2171, AZD2171, Cediranib Maleate, AZD2171 Maleate, Recentin, Computed Tomography, CAT, CAT Scan, Computed Axial Tomography, Computerized Axial Tomography, Computerized axial tomography (procedure), Computerized Tomography, Computerized Tomography (CT) scan, CT, CT Scan, tomography, Durvalumab, Imfinzi, Immunoglobulin G1, Anti-(Human Protein B7-H1) (Human Monoclonal MEDI4736 Heavy Chain), Disulfide with Human Monoclonal MEDI4736 Kappa-chain, Dimer, MEDI 4736, MEDI-4736, MEDI4736, Echocardiography, EC, Multigated Acquisition Scan, Blood Pool Scan, Equilibrium Radionuclide Angiography, Gated Blood Pool Imaging, Gated Heart Pool Scan, MUGA, MUGA Scan, Multi-Gated Acquisition Scan, Radionuclide Ventriculogram Scan, Radionuclide Ventriculography, RNV Scan, RNVG, SYMA Scanning, Synchronized Multigated Acquisition Scanning, Olaparib, AZD 2281, AZD-2281, AZD2281, KU 0059436, KU-0059436, KU0059436, Lynparza, Olanib, Olaparix, PARP Inhibitor AZD2281
National Cancer Institute (NCI), NRG Oncology
Endometrial Adenocarcinoma, Endometrial Mixed Cell Adenocarcinoma, Endometrial Serous Adenocarcinoma, Endometrial Undifferentiated Carcinoma, Endometrioid Adenocarcinoma, Stage IV Uterine Corpus Cancer AJCC v8
12/24
01/26
NRG-GY025, NCT05112601: Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma

Recruiting
2
90
US
Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Computed Tomography, CAT, CAT Scan, Computed Axial Tomography, Computerized Axial Tomography, Computerized axial tomography (procedure), Computerized Tomography, Computerized Tomography (CT) scan, CT, CT Scan, tomography, Ipilimumab, Anti-Cytotoxic T-Lymphocyte-Associated Antigen-4 Monoclonal Antibody, BMS 734016, BMS-734016, BMS734016, Ipilimumab Biosimilar CS1002, MDX 010, MDX-010, MDX-CTLA4, MDX010, Yervoy, Magnetic Resonance Imaging, Magnetic Resonance, Magnetic Resonance Imaging (MRI), Magnetic resonance imaging (procedure), Magnetic Resonance Imaging Scan, Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance, MR, MR Imaging, MRI, MRI Scan, MRIs, NMR Imaging, NMRI, Nuclear Magnetic Resonance Imaging, sMRI, Structural MRI, Nivolumab, ABP 206, BCD-263, BMS 936558, BMS-936558, BMS936558, CMAB819, MDX 1106, MDX-1106, MDX1106, NIVO, Nivolumab Biosimilar ABP 206, Nivolumab Biosimilar BCD-263, Nivolumab Biosimilar CMAB819, ONO 4538, ONO-4538, ONO4538, Opdivo
National Cancer Institute (NCI), NRG Oncology
Endometrial Adenocarcinoma, Endometrial Clear Cell Adenocarcinoma, Endometrial Dedifferentiated Carcinoma, Endometrial Endometrioid Adenocarcinoma, Endometrial Mixed Cell Adenocarcinoma, Endometrial Mucinous Adenocarcinoma, Endometrial Undifferentiated Carcinoma, Endometrioid Adenocarcinoma, Recurrent Endometrial Carcinoma
04/26
04/26
NRG-GY028, NCT05538897: Testing the Addition of the AKT Inhibitor, Ipatasertib, to Treatment With the Hormonal Agent Megestrol Acetate for Recurrent or Metastatic Endometrial Cancers

Recruiting
1/2
96
US
Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Computed Tomography, CAT, CAT Scan, Computed Axial Tomography, Computerized Axial Tomography, Computerized axial tomography (procedure), Computerized Tomography, Computerized Tomography (CT) scan, CT, CT Scan, tomography, Ipatasertib, GDC 0068, GDC-0068, GDC0068, RG 7440, RG-7440, RG7440, Magnetic Resonance Imaging, Magnetic Resonance, Magnetic Resonance Imaging (MRI), Magnetic resonance imaging (procedure), Magnetic Resonance Imaging Scan, Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance, MR, MR Imaging, MRI, MRI Scan, MRIs, NMR Imaging, NMRI, Nuclear Magnetic Resonance Imaging, sMRI, Structural MRI, Megestrol Acetate, 17-Hydroxy-6-methylpregna-4,6-diene-3,20-dione acetate, 17.alpha.-Acetoxy-6-methylpregna-4,6-diene-3,20-dione, 6-Dehydro-6-methyl-17.alpha.-acetoxyprogesterone, 6-Methyl-6-dehydro-17.alpha.-acetoxyprogesterone, BDH 1298, BDH-1298, Maygace, Megace, Megestat, Megestil, Niagestin, Ovaban, Pallace, SC 10363, SC-10363
National Cancer Institute (NCI), NRG Oncology
FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma, FIGO Grade 2 Endometrial Endometrioid Adenocarcinoma, Metastatic Endometrial Endometrioid Adenocarcinoma, Recurrent Endometrial Endometrioid Adenocarcinoma
01/27
01/27
NRG-GY022, NCT03997370: Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast Agent Iohexol

Recruiting
1
350
US
Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Carboplatin, Blastocarb, Carboplat, Carboplatin Hexal, Carboplatino, Carboplatinum, Carbosin, Carbosol, Carbotec, CBDCA, Displata, Ercar, JM-8, JM8, Nealorin, Novoplatinum, Paraplatin, Paraplatin AQ, Paraplatine, Platinwas, Ribocarbo, Iohexol, Omnipaque
NRG Oncology, National Cancer Institute (NCI)
Malignant Solid Neoplasm
02/27
02/28
NCT06000475: Enhancing Memory in CPT for PTSD

Enrolling by invitation
N/A
30
US
Cognitive Processing Therapy, CPT, Cognitive Processing Therapy (CPT) + Memory Support
VA Office of Research and Development
Stress Disorders, Post-Traumatic
12/25
12/25
NCT00539162: Use of the CA 125 Algorithm for the Early Detection of Ovarian Cancer in Low Risk Women

Recruiting
N/A
8000
US
Questionnaire, Survey
M.D. Anderson Cancer Center, National Cancer Institute (NCI), Golfers Against Cancer
Ovarian Cancer
11/28
11/28
SOROCk, NCT04251052: A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

Recruiting
N/A
2262
Canada, US, RoW
Bilateral Salpingectomy, Bilateral Salpingectomy with Oophorectomy, bilateral salpingo-oophorectomy, Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Quality-of-Life Assessment, Quality of Life Assessment, Questionnaire Administration, Transvaginal Ultrasound, transvaginal sonography, TVS, TVU, Ultrasound Imaging, 2-Dimensional Grayscale Ultrasound Imaging, 2-Dimensional Ultrasound Imaging, 2D-US, Ultrasonography, Ultrasound, Ultrasound Test, Ultrasound, Medical, US
NRG Oncology, National Cancer Institute (NCI)
Ovarian Carcinoma
06/36
06/37
Vohr, Betty R
I-ACQUIRE, NCT03910075: Perinatal Arterial Stroke: A Multi-site RCT of Intensive Infant Rehabilitation

Active, not recruiting
3
216
US
I-ACQUIRE - High Dosage, ACQUIRE, Pediatric Constraint-Induced Movement Therapy, P-CIMT, I-ACQUIRE - Moderate Dosage, Usual & Customary Treatment (U&CT)
Virginia Polytechnic Institute and State University, Ohio State University, Nationwide Children's Hospital, Stanford University, University of Cincinnati, Medical University of South Carolina
Perinatal Stroke, Hemiparesis
10/25
05/26
NCT03688386: A Language Intervention Study of Preterm Infants

Active, not recruiting
N/A
67
US
Reading intervention, Infant bonding, LENA recording, LENA linguistic feedback, LENA summary
Women and Infants Hospital of Rhode Island
Language Development, Language Delay, Mother-Infant Interaction, Maternal Behavior
03/20
06/21
NCT00009633: Follow-up Visit of High Risk Infants

Recruiting
N/A
68000
US
NICHD Neonatal Research Network, National Center for Research Resources (NCRR), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Infant, Newborn, Infant, Low Birth Weight, Infant, Small for Gestational Age, Infant, Premature
03/30
03/30
Smith, Petra
SURE, NCT04218864: Strength for U in Relationship Empowerment

Active, not recruiting
N/A
186
US
Strength for U in Relationship Empowerment (SURE), Attention, time, and information matched control
Women and Infants Hospital of Rhode Island, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
IPV, Perinatal, Mental Health
01/25
01/25
Mathews, Cara
NRG-GY026, NCT05256225: Testing the Addition of Trastuzumab or Trastuzumab/Pertuzumab to the Usual Chemotherapy for HER2 Positive Endometrial Cancer

Recruiting
2/3
525
US
Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Carboplatin, Blastocarb, Carboplat, Carboplatin Hexal, Carboplatino, Carboplatinum, Carbosin, Carbosol, Carbotec, CBDCA, Displata, Ercar, JM-8, JM8, Nealorin, Novoplatinum, Paraplatin, Paraplatin AQ, Paraplatine, Platinwas, Ribocarbo, Computed Tomography, CAT, CAT Scan, Computed Axial Tomography, Computerized Axial Tomography, Computerized axial tomography (procedure), Computerized Tomography, Computerized Tomography (CT) scan, CT, CT Scan, tomography, Echocardiography, EC, High-Dose-Rate Vaginal Cuff Brachytherapy, HDR-VCB, Hyaluronidase-zzxf/Pertuzumab/Trastuzumab, Pertuzumab and Trastuzumab hyaluronidase, Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf, Pertuzumab/Trastuzumab/Hyaluronidase-zzxf, Phesgo, Multigated Acquisition Scan, Blood Pool Scan, Equilibrium Radionuclide Angiography, Gated Blood Pool Imaging, MUGA, Radionuclide Ventriculography, RNVG, SYMA Scanning, Synchronized Multigated Acquisition Scanning, Paclitaxel, Anzatax, Asotax, Bristaxol, Praxel, Taxol, Taxol Konzentrat, Quality-of-Life Assessment, Quality of Life Assessment, Trastuzumab/Hyaluronidase-oysk, Herceptin Hylecta, Trastuzumab and Hyaluronidase, Trastuzumab and Hyaluronidase-oysk, Trastuzumab and Recombinant Human Hyaluronidase PH20, Trastuzumab and rHuPH20, Trastuzumab-Hyaluronidase-oysk
National Cancer Institute (NCI), NRG Oncology
Endometrial Carcinoma, Endometrial Clear Cell Adenocarcinoma, Endometrial Dedifferentiated Carcinoma, Endometrial Endometrioid Adenocarcinoma, Endometrial Mixed Cell Adenocarcinoma, Endometrial Serous Adenocarcinoma, Endometrial Undifferentiated Carcinoma, Uterine Corpus Carcinosarcoma
10/27
10/27
PROFECTA-II, NCT04374630: Study With Afuresertib and Paclitaxel in Platinum Resistant Ovarian

Completed
2
150
US, RoW
Paclitaxel, Afuresertib, LAE002
Laekna Limited
Platinum-resistant Ovarian Cancer
07/23
06/24
PICCOLO, NCT05041257: Mirvetuximab Soravtansine Monotherapy in Platinum-Sensitive Epithelial, Peritoneal, and Fallopian Tube Cancers

Hourglass Oct 2024 - Dec 2024 : Approval for 2L+ FRα +ve PROC
Hourglass Jan 2024 - Jun 2024 : sBLA approval for ovarian cancer
Hourglass Jan 2024 - Jun 2024 : FDA action date for approval for ovarian cancer with high FRAC
Hourglass Jan 2023 - Dec 2023 : ORR data from PICCOLO trial for platinum sensitive ovarian cancer
Completed
2
79
Europe, Canada, US, RoW
Mirvetuximab soravtansine, MIRV, IMGN853
AbbVie
Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer
01/24
12/24
NCI-2017-01672, NCT03660826: Testing the Combination of Olaparib and Durvalumab, Cediranib and Durvalumab, Olaparib and Capivasertib, and Cediranib Alone in Recurrent or Refractory Endometrial Cancer Following the Earlier Phase of the Study That Tested Olaparib and Cediranib in Comparison to Cediranib Alone, and Olaparib Alone

Active, not recruiting
2
286
Canada, US
Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Bone Marrow Aspirate, BONE MARROW, LIQUID, Human Bone Marrow Aspirate, Bone Marrow Biopsy, Biopsy of Bone Marrow, Biopsy, Bone Marrow, Capivasertib, AZD 5363, AZD-5363, AZD5363, Truqap, Cediranib, AZ-D2171, AZD 2171, AZD2171, Cediranib Maleate, AZD2171 Maleate, Recentin, Computed Tomography, CAT, CAT Scan, Computed Axial Tomography, Computerized Axial Tomography, Computerized axial tomography (procedure), Computerized Tomography, Computerized Tomography (CT) scan, CT, CT Scan, tomography, Durvalumab, Imfinzi, Immunoglobulin G1, Anti-(Human Protein B7-H1) (Human Monoclonal MEDI4736 Heavy Chain), Disulfide with Human Monoclonal MEDI4736 Kappa-chain, Dimer, MEDI 4736, MEDI-4736, MEDI4736, Echocardiography, EC, Multigated Acquisition Scan, Blood Pool Scan, Equilibrium Radionuclide Angiography, Gated Blood Pool Imaging, Gated Heart Pool Scan, MUGA, MUGA Scan, Multi-Gated Acquisition Scan, Radionuclide Ventriculogram Scan, Radionuclide Ventriculography, RNV Scan, RNVG, SYMA Scanning, Synchronized Multigated Acquisition Scanning, Olaparib, AZD 2281, AZD-2281, AZD2281, KU 0059436, KU-0059436, KU0059436, Lynparza, Olanib, Olaparix, PARP Inhibitor AZD2281
National Cancer Institute (NCI), NRG Oncology
Endometrial Adenocarcinoma, Endometrial Mixed Cell Adenocarcinoma, Endometrial Serous Adenocarcinoma, Endometrial Undifferentiated Carcinoma, Endometrioid Adenocarcinoma, Stage IV Uterine Corpus Cancer AJCC v8
12/24
01/26
BrUOG 354, NCT03355976: Nivolumab +/- Ipilimumab for Ovarian and Extra-renal Clear Cell Carcinomas

Active, not recruiting
2
46
US
Nivolumab, Ipilimumab
Brown University, Bristol-Myers Squibb, Rhode Island Hospital, The Miriam Hospital, Women and Infants Hospital of Rhode Island
Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma, Extra Renal Origin, Clear Cell Adenocarcinoma
03/25
06/25
NCT05456685: Mirvetuximab Soravtansine (MIRV) With Carboplatin in Second-line Treatment of Folate Receptor Alpha (FRα) Expressing, Platinum-sensitive Epithelial Ovarian Cancer

Checkmark Data from trial in combination with carboplatin for platinum-sensitive epithelial ovarian cancer at IGCS 2022
Sep 2022 - Oct 2022: Data from trial in combination with carboplatin for platinum-sensitive epithelial ovarian cancer at IGCS 2022
Active, not recruiting
2
125
Europe, Canada, US, RoW
Mirvetuximab soravtansine, MIRV, IGN853, Carboplatin
AbbVie
High Grade Ovarian Cancer, Primary Peritoneal Cancer, Fallopian Tube Cancer
05/26
05/26
EEC-201, NCT05997017: Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial Cancer

Recruiting
2
29
US
nab-sirolimus, ABI-009
Aadi Bioscience, Inc.
Endometrial Cancer, Endometrioid Tumor, Cancer, Tumor, Recurrent Endometrial Carcinoma, Endometrioid Endometrial Cancer
03/25
10/26
NRG-GY025, NCT05112601: Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma

Recruiting
2
90
US
Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Computed Tomography, CAT, CAT Scan, Computed Axial Tomography, Computerized Axial Tomography, Computerized axial tomography (procedure), Computerized Tomography, Computerized Tomography (CT) scan, CT, CT Scan, tomography, Ipilimumab, Anti-Cytotoxic T-Lymphocyte-Associated Antigen-4 Monoclonal Antibody, BMS 734016, BMS-734016, BMS734016, Ipilimumab Biosimilar CS1002, MDX 010, MDX-010, MDX-CTLA4, MDX010, Yervoy, Magnetic Resonance Imaging, Magnetic Resonance, Magnetic Resonance Imaging (MRI), Magnetic resonance imaging (procedure), Magnetic Resonance Imaging Scan, Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance, MR, MR Imaging, MRI, MRI Scan, MRIs, NMR Imaging, NMRI, Nuclear Magnetic Resonance Imaging, sMRI, Structural MRI, Nivolumab, ABP 206, BCD-263, BMS 936558, BMS-936558, BMS936558, CMAB819, MDX 1106, MDX-1106, MDX1106, NIVO, Nivolumab Biosimilar ABP 206, Nivolumab Biosimilar BCD-263, Nivolumab Biosimilar CMAB819, ONO 4538, ONO-4538, ONO4538, Opdivo
National Cancer Institute (NCI), NRG Oncology
Endometrial Adenocarcinoma, Endometrial Clear Cell Adenocarcinoma, Endometrial Dedifferentiated Carcinoma, Endometrial Endometrioid Adenocarcinoma, Endometrial Mixed Cell Adenocarcinoma, Endometrial Mucinous Adenocarcinoma, Endometrial Undifferentiated Carcinoma, Endometrioid Adenocarcinoma, Recurrent Endometrial Carcinoma
04/26
04/26
NCT04577963: A Study of Fruquintinib in Combination With Tislelizumab in Advanced Solid Tumors

Active, not recruiting
1/2
112
US
Fruquintinib, HMPL-013, Tislelizumab, BGB-A317
Hutchison Medipharma Limited, BeiGene
Triple Negative Breast Cancer, Endometrial Cancer, Solid Tumor, Unspecified, Adult, Colorectal Cancer
07/24
11/24
ELU-FRα-1, NCT05001282: A Study to Evaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRα)

Terminated
1/2
79
US
ELU001, FA-CDC
Elucida Oncology
Ovarian Cancer, Ovarian Neoplasms, Ovarian Carcinoma, Endometrial Cancer, Ovary Cancer, Ovary Neoplasm, Ovary Disease, Ovary Metastasis, Ovarian Diseases, Ovarian Cancer Stage, Ovarian Epithelial Cancer, Ovarian Adenocarcinoma, Ovarian Serous Adenocarcinoma, Ovarian Neoplasm Epithelial, Ovarian Cancer Recurrent, Endometrial Diseases, Endometrial Adenocarcinoma, Endometrial Carcinosarcoma, Endometrial Clear Cell Adenocarcinoma, Endometrioid Adenocarcinoma, Endometrial Neoplasms, Endometrial Cancer Recurrent, Endometrioid Tumor, Fallopian Tube Cancer, Peritoneal Cancer
06/24
06/24
ACR-368-201, NCT05548296: A Study of ACR-368 in Ovarian Carcinoma, Endometrial Adenocarcinoma, and Urothelial Carcinoma

Recruiting
1/2
390
US
ACR-368, prexasertib, Gemcitabine, OncoSignature
Acrivon Therapeutics, GOG Foundation
Platinum-resistant Ovarian Cancer, Endometrial Adenocarcinoma, Urothelial Carcinoma
07/26
12/27
NRG-GY028, NCT05538897: Testing the Addition of the AKT Inhibitor, Ipatasertib, to Treatment With the Hormonal Agent Megestrol Acetate for Recurrent or Metastatic Endometrial Cancers

Recruiting
1/2
96
US
Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Computed Tomography, CAT, CAT Scan, Computed Axial Tomography, Computerized Axial Tomography, Computerized axial tomography (procedure), Computerized Tomography, Computerized Tomography (CT) scan, CT, CT Scan, tomography, Ipatasertib, GDC 0068, GDC-0068, GDC0068, RG 7440, RG-7440, RG7440, Magnetic Resonance Imaging, Magnetic Resonance, Magnetic Resonance Imaging (MRI), Magnetic resonance imaging (procedure), Magnetic Resonance Imaging Scan, Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance, MR, MR Imaging, MRI, MRI Scan, MRIs, NMR Imaging, NMRI, Nuclear Magnetic Resonance Imaging, sMRI, Structural MRI, Megestrol Acetate, 17-Hydroxy-6-methylpregna-4,6-diene-3,20-dione acetate, 17.alpha.-Acetoxy-6-methylpregna-4,6-diene-3,20-dione, 6-Dehydro-6-methyl-17.alpha.-acetoxyprogesterone, 6-Methyl-6-dehydro-17.alpha.-acetoxyprogesterone, BDH 1298, BDH-1298, Maygace, Megace, Megestat, Megestil, Niagestin, Ovaban, Pallace, SC 10363, SC-10363
National Cancer Institute (NCI), NRG Oncology
FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma, FIGO Grade 2 Endometrial Endometrioid Adenocarcinoma, Metastatic Endometrial Endometrioid Adenocarcinoma, Recurrent Endometrial Endometrioid Adenocarcinoma
01/27
01/27
NRG-GY027, NCT05276973: Testing the Addition of Ipatasertib to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) for Stage III or IV Epithelial Ovarian Cancer

Active, not recruiting
1
24
US
Biopsy, BIOPSY_TYPE, Bx, Carboplatin, Blastocarb, Carboplat, Carboplatin Hexal, Carboplatino, Carboplatinum, Carbosin, Carbosol, Carbotec, CBDCA, Displata, Ercar, JM-8, JM8, Nealorin, Novoplatinum, Paraplatin, Paraplatin AQ, Paraplatine, Platinwas, Ribocarbo, Ipatasertib, GDC 0068, GDC-0068, GDC0068, RG 7440, RG-7440, RG7440, Paclitaxel, Anzatax, Asotax, Bristaxol, Praxel, Taxol, Taxol Konzentrat
National Cancer Institute (NCI), NRG Oncology
Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian High Grade Serous Adenocarcinoma, Primary Peritoneal Endometrioid Adenocarcinoma, Primary Peritoneal High Grade Serous Adenocarcinoma, Stage III Fallopian Tube Cancer AJCC v8, Stage III Ovarian Cancer AJCC v8, Stage III Primary Peritoneal Cancer AJCC v8, Stage IV Fallopian Tube Cancer AJCC v8, Stage IV Ovarian Cancer AJCC v8, Stage IV Primary Peritoneal Cancer AJCC v8, Unresectable Fallopian Tube Endometrioid Adenocarcinoma, Unresectable Fallopian Tube High Grade Serous Adenocarcinoma, Unresectable Ovarian Endometrioid Adenocarcinoma, Unresectable Ovarian High Grade Serous Adenocarcinoma, Unresectable Primary Peritoneal Endometrioid Adenocarcinoma, Unresectable Primary Peritoneal High Grade Serous Adenocarcinoma
01/25
01/25
NRG-GY031, NCT05950464: Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the Treatment of Recurrent Ovarian and Endometrial Cancer

Recruiting
1
60
US
BET Bromodomain Inhibitor ZEN-3694, BETi ZEN-3694, ZEN 3694, ZEN-3694, ZEN003694, Biopsy, BIOPSY_TYPE, Bx, Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Computed Tomography, CAT, CAT Scan, Computed Axial Tomography, Computerized Axial Tomography, Computerized axial tomography (procedure), Computerized Tomography, Computerized Tomography (CT) scan, CT, CT Scan, tomography, Electrocardiography, ECG, EKG, Magnetic Resonance Imaging, Magnetic Resonance, Magnetic Resonance Imaging (MRI), Magnetic resonance imaging (procedure), Magnetic Resonance Imaging Scan, Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance, MR, MR Imaging, MRI, MRI Scan, MRIs, NMR Imaging, NMRI, Nuclear Magnetic Resonance Imaging, sMRI, Structural MRI, Tuvusertib, ATR Kinase Inhibitor M1774, M 1774, M-1774, M1774, X-Ray Imaging, Conventional X-Ray, Diagnostic Radiology, Medical Imaging, X-Ray, Plain film radiographs, Radiographic Imaging, Radiographic imaging procedure (procedure), Radiography, RG, Static X-Ray, X-Ray
National Cancer Institute (NCI), NRG Oncology
Endometrial Carcinoma, Endometrial Clear Cell Adenocarcinoma, Endometrial Endometrioid Adenocarcinoma, Endometrial Low Grade Endometrioid Adenocarcinoma, Ovarian Clear Cell Adenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian High Grade Serous Adenocarcinoma, Ovarian Low Grade Endometrioid Adenocarcinoma, Platinum-Resistant Ovarian Carcinoma
04/26
04/26
GARNET, NCT02715284: Study of TSR-042, an Anti-programmed Cell Death-1 Receptor (PD-1) Monoclonal Antibody, in Participants With Advanced Solid Tumors

Checkmark MFDS approved in Korea in adult patients with recurrent or advanced dMMR/MSI-H 2L endometrial cancer
Dec 2022 - Dec 2022: MFDS approved in Korea in adult patients with recurrent or advanced dMMR/MSI-H 2L endometrial cancer
Checkmark Result from GARNET trial for dMMR endometrial cancer and other solid tumors at ESMO 2022
Sep 2022 - Sep 2022: Result from GARNET trial for dMMR endometrial cancer and other solid tumors at ESMO 2022
Checkmark Approved for recurrent or advanced endometrial cancer
More
Recruiting
1
740
Europe, Canada, US, RoW
Dostarlimab
Tesaro, Inc.
Neoplasms
05/26
10/27
Fournier, Simone
SURE, NCT04218864: Strength for U in Relationship Empowerment

Active, not recruiting
N/A
186
US
Strength for U in Relationship Empowerment (SURE), Attention, time, and information matched control
Women and Infants Hospital of Rhode Island, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
IPV, Perinatal, Mental Health
01/25
01/25
Coordinator, Senior Project
MAMMOTH, NCT05198804 / 2021-004161-13: A Study of ZN-c3 and Niraparib in Subjects With Platinum-Resistant Ovarian Cancer

Hourglass Jul 2024 - Dec 2024 : Topline data for platinum resistant ovarian cancer
Active, not recruiting
1/2
117
Europe, US
ZN-c3, Niraparib
K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc, K-Group Beta, Inc.
Ovarian Cancer, Platinum-resistant Ovarian Cancer, Primary Peritoneal Carcinoma, Fallopian Tube Cancer
05/25
05/25

Download Options